glp-1 long-term risks The Trap: Your Jumpstart Might Be a Forever Commitment Can You Stop Taking GLP‑1
Description
Box 1: Recent Trump Administration Obesity Drug Initiatives In November 2025, the Trump administration announced reaching a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1s for Medicare, Medicaid, and those purchasing the drugs directly from the manufacturers through a new TrumpRx website

Brain Res (2015) 1627:1018

Going forward, youll receive two formats alternating each week: our regular This Week in AI newsletter and a deep-dive case study on how companies are actually using AI to win Hope you like this initiative!

For type 2 diabetes, denials are often fixable
Acknowledgements We appreciate the sincere effort and support of Professor Monir Bahgat Hussein, Professor of Gastroenterology and Hepatology, Faculty of Medicine, Mansoura University
What you build on it is still up to you
